Eric Wong's questions to Kymera Therapeutics Inc (KYMR) leadership • Q4 2024
Question
Eric Wong of The Goldman Sachs Group, Inc. inquired about Kymera's strategy for strategic partnerships beyond the Sanofi deal, particularly asking about the criteria for selecting partners for its oncology assets.
Answer
CEO Nello Mainolfi stated that the immunology pipeline will be advanced independently for now. For oncology, he reiterated the strategy to partner programs after Phase I. The criteria for a partner is a 'win-win' situation with a company that is driven, interested, and has the capabilities to successfully develop the asset.